Ikunobu Muramatsu Selected Research

Ikunobu Muramatsu Research Topics

Disease

3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2023 - 01/2017
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2015 - 03/2006
2	Inflammation (Inflammations) 12/2020 - 08/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 11/2016
1	Rheumatoid Arthritis 12/2020
1	Brain Ischemia (Cerebral Ischemia) 12/2020
1	Shock 11/2019
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Hyperalgesia 01/2016
1	Pain (Aches) 01/2016
1	Lower Urinary Tract Symptoms 03/2015
1	Stress Urinary Incontinence 11/2013
1	Neuroblastoma 09/2011
1	Neurogenic Inflammation 09/2006
1	Leukocytosis (Pleocytosis) 11/2003
1	Hypotension (Low Blood Pressure) 04/2002
1	Septic Shock (Toxic Shock Syndrome) 04/2002
1	Sepsis (Septicemia) 04/2002

Drug/Important Bio-Agent (IBA)

3	Cholinergic Agents (Cholinergics)IBA 01/2019 - 09/2006
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 03/2023 - 09/2011
2	CytokinesIBA 01/2017 - 04/2002
2	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2013 - 04/2002
2	Peroxynitrous Acid (Peroxynitrite)IBA 11/2003 - 04/2002
1	1- (5- chloro- 2,4- dimethoxyphenyl)- 3- (5- methylisoxazol- 3- yl)ureaIBA 12/2020
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2019
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 11/2019
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Rivastigmine (Exelon)FDA LinkGeneric 11/2016
1	Isoflurophate (DFP)FDA Link 11/2016
1	Choline (Choline Chloride)IBA 11/2016
1	EsterasesIBA 11/2016
1	Galantamine (Galanthamine)FDA LinkGeneric 11/2016
1	Donepezil (Aricept)FDA LinkGeneric 11/2016
1	3,4-dihydroxyphenylglycolIBA 01/2016
1	metabotropic glutamate receptor type 1IBA 01/2016
1	Quisqualic AcidIBA 01/2016
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	Dutasteride (Avodart)FDA Link 03/2015
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 03/2015
1	3'- (2- amino- 1- hydroxyethyl)- 4'- fluoromethanesulfonanilideIBA 11/2013
1	dabuzalgronIBA 11/2013
1	Phosphotransferases (Kinase)IBA 08/2013
1	ChloridesIBA 08/2013
1	Proteins (Proteins, Gene)FDA Link 02/2010
1	Local AnestheticsIBA 09/2006
1	TachykininsIBA 09/2006
1	Neurotransmitter Agents (Neurotransmitter)IBA 09/2006
1	Tamsulosin (Flomax)FDA LinkGeneric 03/2006
1	silodosin FDA Link 03/2006
1	naftopidilIBA 03/2006
1	Interleukin-8 (Interleukin 8)IBA 11/2003
1	Nicotine FDA Link 11/2003
1	NF-kappa B (NF-kB)IBA 11/2003
1	EndotoxinsIBA 04/2002
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2002
1	Nitric Oxide Synthase (NO Synthase)IBA 04/2002
1	Vasoconstrictor AgentsIBA 04/2002
1	CatecholaminesIBA 04/2002

Therapy/Procedure

2	Therapeutics 11/2013 - 02/2010